A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us.

Case study with first patient images of half-life engineered MP0712 from compassionate care use show specific uptake in primary tumors and ...

One person's side effect could be another person's treatment if we expand our perspective on small molecule drug targets, ...

Governments are centralizing health systems when the transformative technology of our era depends on decentralization.

Biliary atresia (BA) represents one of the leading causes of pediatric liver failure, often requiring surgical intervention ...

Announced extraordinary 86% overall survival at 9 months in first-line pancreatic cancer patients treated with atebimetinib + mGnP -- Raised ...

Why treat people and send them back to the conditions that make them sick?”, one of us (Michael Marmot) has asked, based on overwhelming evidence that social forces are among the strongest ...

A New Jersey dad who collapsed and died after eating a hamburger has been identified as the first known fatality from a rare ...

A PIDS study says PhilHealth's All Case Rates (ACR) are obsolete, resulting in $\text{98.8\%}$ of claims exceeding reimbursement. It calls for a transition to the Diagnosis-Related Groups (DRG) model ...

A naturally-occurring protein that tends to be expressed at higher levels in breast cancer cells boosts the effectiveness of ...

Chatbots are cheap, always available, superficially empathetic — and sometimes wrong. Some have concluded they’re a risk ...